Regulon

Regulon: R-847

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
42-0.99220410Pr-134Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
54455 ENSG00000037637 FBXO42 X6RKU3
23517 ENSG00000039123 SKIV2L2 P42285
55718 ENSG00000058600 POLR3E Q9NVU0
63897 ENSG00000068097 HEATR6 Q6AI08
55205 ENSG00000074657 ZNF532 Q9HCE3
9733 ENSG00000075856 SART3 Q15020
54665 ENSG00000081019 RSBN1 Q5VWQ0
8555 ENSG00000081377 CDC14B O60729
8898 ENSG00000087053 MTMR2 A0A6Q8PGT1
11198 ENSG00000092201 SUPT16H Q9Y5B9
9777 ENSG00000101337 TM9SF4 Q92544
22919 ENSG00000101367 MAPRE1 Q15691
23347 ENSG00000101596 SMCHD1 A6NHR9
55756 ENSG00000104299 INTS9 Q9NV88
642 ENSG00000108578 BLMH Q13867
1665 ENSG00000109606 DHX15 O43143
6421 ENSG00000116560 SFPQ P23246
10274 ENSG00000118007 STAG1 Q8WVM7
56252 ENSG00000119596 YLPM1 P49750
23435 ENSG00000120948 TARDBP G3V162
5894 ENSG00000132155 RAF1 A0A8I5KR46
3178 ENSG00000135486 HNRNPA1 P09651
55316 ENSG00000136444 RSAD1 Q9HA92
5495 ENSG00000138032 PPM1B O75688
25800 ENSG00000141424 SLC39A6 Q13433
10262 ENSG00000143368 SF3B4 Q15427
142 ENSG00000143799 PARP1 P09874
51631 ENSG00000146963 LUC7L2 Q9Y383
4841 ENSG00000147140 NONO Q15233
1105 ENSG00000153922 CHD1 O14646
22976 ENSG00000157212 PAXIP1 Q6ZW49
23358 ENSG00000162402 USP24 Q9UPU5
26130 ENSG00000165219 GAPVD1 Q14C86
65110 ENSG00000169062 UPF3A Q9H1J1
5747 ENSG00000169398 PTK2 E5RH01
171023 ENSG00000171456 ASXL1 Q8IXJ9
7690 ENSG00000172262 ZNF131 P52739
10949 ENSG00000177733 HNRNPA0 Q13151
30849 ENSG00000196455 PIK3R4 Q99570
10137 ENSG00000244462 RBM12 Q9NTZ6
9939 ENSG00000265241 RBM8A Q9Y5S9
55802 ENSG00000272886 DCP1A Q9NPI6

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
RUCAPARIBPARP1Small moleculeINHIBITORPARP 1, 2 and 3 inhibitor40
PAMIPARIBPARP1Small moleculeINHIBITORPoly [ADP-ribose] polymerase-1 inhibitor31
XL-281RAF1Small moleculeINHIBITORSerine/threonine-protein kinase RAF inhibitor20
GSK-2256098PTK2Small moleculeINHIBITORFocal adhesion kinase 1 inhibitor20
LADIRATUZUMAB VEDOTINTUBB1AntibodyINHIBITORTubulin inhibitor20
SORAFENIB TOSYLATEPDGFRBSmall moleculeINHIBITORStem cell growth factor receptor inhibitor42
BI-853520PTK2Small moleculeINHIBITORFocal adhesion kinase 1 inhibitor10
MLN-2480RAF1Small moleculeINHIBITORRAF serine/threonine protein kinase inhibitor10
OLAPARIBPARP1Small moleculeINHIBITORPARP 1, 2 and 3 inhibitor42
SORAFENIBFLT3Small moleculeINHIBITORStem cell growth factor receptor inhibitor42
TALAZOPARIBPARP1Small moleculeINHIBITORPoly [ADP-ribose] polymerase 2 inhibitor42
VS-4718PTK2Small moleculeINHIBITORFocal adhesion kinase 1 inhibitor10
DEFACTINIBPTK2BSmall moleculeINHIBITORFocal adhesion kinase 1 inhibitor20
RUCAPARIB CAMSYLATEPARP1Small moleculeINHIBITORPARP 1, 2 and 3 inhibitor40
VELIPARIBPARP1Small moleculeINHIBITORPARP 1, 2 and 3 inhibitor32
ARQ-736RAF1Small moleculeINHIBITORSerine/threonine-protein kinase RAF inhibitor10
2X-121TNKS2Small moleculeINHIBITORPoly [ADP-ribose] polymerase-1 inhibitor20
NIRAPARIBPARP2Small moleculeINHIBITORPoly [ADP-ribose] polymerase 2 inhibitor42
LY-3009120ARAFSmall moleculeINHIBITORSerine/threonine-protein kinase A-Raf inhibitor10
LXH254RAF1Small moleculeINHIBITORB-raf/RAF proto-oncogene serine/threonine-protein kinase inhibitor20
NIRAPARIB TOSYLATEPARP1Small moleculeINHIBITORPoly [ADP-ribose] polymerase 2 inhibitor40
CEP-37440ALKSmall moleculeINHIBITORFocal adhesion kinase 1 inhibitor10
TALAZOPARIB TOSYLATEPARP1Small moleculeINHIBITORPoly [ADP-ribose] polymerase 2 inhibitor40
REGORAFENIBKDRSmall moleculeINHIBITORTyrosine-protein kinase TIE-2 inhibitor42
CONTELTINIBPTK2Small moleculeINHIBITORProtein tyrosine kinase 2 beta inhibitor10
BELVARAFENIBRAF1Small moleculeINHIBITORRAF serine/threonine protein kinase inhibitor20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-847

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs